ETST is a biotechnology company. The Firm focuses on cannabis and cannabinoid research and development, nutraceuticals, pharmaceuticals, bioceuticals, phytoceuticals and cosmeceuticals for the health, wellness and alternative medicine markets. It currently has negative earnings. The Firm is dedicated to providing natural alternatives to prescription medications through the use of its nutritional and dietary supplements that help with alleviating symptoms such as: chronic pain, joint pain, inflammation, seizures and high blood pressure.
